Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) )

Int J Dermatol. 2014 Mar;53(3):e190-2. doi: 10.1111/j.1365-4632.2012.05780.x. Epub 2013 May 15.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Erlotinib Hydrochloride
  • Female
  • Hand-Foot Syndrome / etiology*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / adverse effects*
  • Quinazolines / adverse effects*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride